Cargando…
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
The use of low sub-perceptual doses of psychedelics (“microdosing”) has gained popularity in recent years. Although anecdotal reports claim multiple benefits associated with this practice, the lack of placebo-controlled studies severely limits our knowledge of microdosing and its effects. Moreover,...
Autores principales: | Cavanna, Federico, Muller, Stephanie, de la Fuente, Laura Alethia, Zamberlan, Federico, Palmucci, Matías, Janeckova, Lucie, Kuchar, Martin, Pallavicini, Carla, Tagliazucchi, Enzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346139/ https://www.ncbi.nlm.nih.gov/pubmed/35918311 http://dx.doi.org/10.1038/s41398-022-02039-0 |
Ejemplares similares
-
Relationship among subjective responses, flavor, and chemical composition across more than 800 commercial cannabis varieties
por: de la Fuente, Alethia, et al.
Publicado: (2020) -
Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting
por: Tagliazucchi, Enzo, et al.
Publicado: (2021) -
Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study
por: van Elk, Michiel, et al.
Publicado: (2021) -
Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study
por: Marschall, Josephine, et al.
Publicado: (2021) -
Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022)